An interventional study of Survivorship care delivery intervention in Cancer Survivorship, sponsored by The University of Texas Health Science Center, Houston. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-24.
Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Health services research
The purpose of this study is to implement a clinic-level cancer survivorship care delivery intervention in partnership with community health center clinicians, patients, and community representatives to test effectiveness of the intervention to improve patient and clinician outcomes and to evaluate implementation of the intervention using an iterative, concurrent mixed-methods approach guided by the Practice Change Model.
The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria (participants):
-at least one visit to the Community Health Centers (CHCs) in the prior year
Exclusion Criteria (participants):
- no history of cancer recorded in the problem list or past medical history in the medical record
Inclusion Criteria (clinicians):
-employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics
Behavioral: Survivorship care delivery intervention
Behavioral: Survivorship care delivery intervention
Behavioral: Survivorship care delivery intervention
Behavioral: Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components: 1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO). 2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care. 3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Proportion of eligible cancer survivors screened for second primary cancers
Data derived from electronic health records
Time frame: every 6 months from baseline to end of study (about 36 months from baseline)
Change in proportion of primary care clinician knowledge of cancer survivorship care
Assessed by self-administered survey
Time frame: baseline, six months following end of intervention period
Change proportion of survivors that report better experience of provider communication as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0)
Time frame: baseline, six months following end of intervention period
Change proportion of survivors that report better experience of care coordination as assessed by the adapted Consumer Assessment of Healthcare Providers and Systems (CAHPS 4.0)
Time frame: baseline, six months following end of intervention period
Proportion of survivors who received guideline-recommended surveillance for the most prevalent cancers (breast colorectal, prostate, cervical, and lung)
Per national guidelines \[National Comprehensive Cancer Network (NCCN), U.S. Preventive Services Task Force (USPSTF)\]; data derived from electronic health records
Time frame: every 6 months from baseline to end of study (about 36 months from baseline)
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston